Search
Search Results
##search.searchResults.foundPlural##
-
TYROSINE KINASE INHIBITORS AND INTERFERON
2948PDF: 1473HTML: 3098Cover Letter: 234 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1851PDF: 908HTML: 1473 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2929PDF: 1052HTML: 5640 -
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1359PDF: 947HTML: 337 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4860PDF: 1602HTML: 2264Untitled: 251Untitled: 265Untitled: 285Untitled: 235Untitled: 253 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2502PDF: 1638HTML: 702 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3445PDF: 2042HTML: 7573 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3865PDF: 1538HTML: 347 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2314PDF: 975HTML: 6859Figure 1: 199 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2303PDF: 753HTML: 2144Untitled: 249Untitled: 171Untitled: 202Untitled: 175Untitled: 193Untitled: 201Untitled: 206 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4922PDF: 1860HTML: 2866Untitled: 251 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1512PDF: 884HTML: 1110Untitled: 199 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3384PDF: 1286HTML: 2365 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1793PDF: 1321HTML: 623 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3309PDF: 1902HTML: 3695 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
3189PDF: 1306HTML: 11860 -
THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA Thalidomide ameliorates erythropoiesis and iron homeostasis
1501PDF: 1470PDF: 1045HTML: 231 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2961PDF: 1146HTML: 476Preferred Reviewers: 233 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
762PDF: 482HTML: 6281 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2437PDF: 1241HTML: 3897 -
ASSOCIATION OF BASELINE PLATELET COUNT WITH COMPLETE REMISSION, SEVERE BLEEDING, AND 24-MONTH OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY
58PDF: 40Suppl. Files: 7Html: 8Html Suppl. Files: 7 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3799PDF: 1305HTML: 3927Untitled: 258Untitled: 290 -
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
1464PDF: 487HTML: 146 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3497PDF: 1332HTML: 2311Fi.1 Gritti.Rambaldi: 232 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4292PDF: 2019HTML: 1956 -
SOLITARY PLASMACYTOMA
4187PDF: 2242HTML: 1399fIGURES 1,2: 252 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3791PDF: 934HTML: 6875







